The number 300,000 almost jumps out of the recent Associated Press story on the results of a study on the role a two-day biotech conference in Boston played in the COVID-19 pandemic. That’s the potential number of cases that can be traced from 29 states and overseas to that meeting last February of Biogen managers,…
You must be a paid subscriber to read this content.
To keep reading and receive unlimited access subscribe today for only $1.
Subscribe Now
Already a Subscriber?
Login now
Want to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.
